Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 8eiq.1

The complex of phosphorylated human delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) with Trikafta [elexacaftor (VX-445), tezacaftor (VX-661), ivacaftor (VX-770)] and ATP/Mg

Coordinates
PDB Format
Method
ELECTRON MICROSCOPY
Oligo State
hetero-1-1-mer
Ligands
2 x MG: MAGNESIUM ION(Non-covalent)
2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
1 x CLR: CHOLESTEROL(Non-covalent)
1 x D12: DODECANE(Non-covalent)
1 x VX7: N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide(Non-covalent)
1 x WJX: (6P)-N-(1,3-dimethyl-1H-pyrazole-4-sulfonyl)-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide(Non-covalent)
1 x CV6: Tezacaftor(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Fiedorczuk, K. et al., Molecular structures reveal synergistic rescue of Delta 508 CFTR by Trikafta modulators. Science (2022)
Release Date
2022-10-19
Peptides
Cystic fibrosis transmembrane conductance regulator: A
Cystic fibrosis transmembrane conductance regulator: B
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
Membrane
We predict this structure to be a membrane protein.

Cystic fibrosis transmembrane conductance regulator

Cystic fibrosis transmembrane conductance regulator

Related Entries With Identical Sequence

1ati.1 | 4wz7.1 | 5aj3.1 | 5fl7.1 | 5nui.1 | 6b3r.1 | 6bk8.1 | 6gmh.1 | 6mpv.1 | 6pxk.1 | 6vzv.1 | 7ado.1 | 7ins.1 | 7ins.4 | 7ins.5 | 7ins.6 | 7ins.8 | 7ins.10 | 7nvr.1 | 7nvv.1 | 7nvx.1 | 7nw0.1 | 7s78.1 | 7s78.2 | 7vdv.1 | 8eig.1 | 8eio.1 | 8ej1.1